LUPUS
Clinical trials for LUPUS explained in plain language.
Never miss a new study
Get alerted when new LUPUS trials appear
Sign up with your email to follow new studies for LUPUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy trial offers hope for Tough-to-Treat autoimmune diseases
Disease control Recruiting nowThis study is testing a new combination treatment for people with severe autoimmune diseases like lupus and scleroderma who haven't responded well to standard therapies. It involves giving specially modified immune cells (AD-PluReceptor-NK cells) along with a drug called tafasita…
Matched conditions: LUPUS
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
First trial tests repurposed drug for rare immune disorder
Disease control Recruiting nowThis study is testing if baricitinib, a drug used for other immune conditions, is safe for people with Job syndrome who also have lupus-like disease or a severe skin rash (atopic dermatitis). It will enroll about 20 participants aged 12 and older. The main goal is to check for si…
Matched conditions: LUPUS
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New oral drug ONTO1 tested for Hard-to-Treat lupus kidney disease
Disease control Recruiting nowThis early-stage study is testing a new oral drug called ONTO1 for people with lupus, including a serious kidney complication called lupus nephritis. The main goal is to find the highest safe dose and see if it helps improve symptoms when taken alongside standard lupus medication…
Matched conditions: LUPUS
Phase: EARLY_PHASE1 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Groundbreaking cell therapy trial offers hope for young lupus patients
Disease control Recruiting nowThis study is testing a personalized cell therapy called CART19 for adolescents and young adults with severe lupus that hasn't responded to standard treatments. Doctors will collect a patient's own immune cells, modify them to target lupus-causing B cells, and reinfuse them. The …
Matched conditions: LUPUS
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Early trial tests stem cell shot for lupus control
Disease control Recruiting nowThis early-stage study is testing whether adding a single injection of stem cells from umbilical cords to standard lupus treatment is safe and tolerable. It will involve 10 adults with active lupus to see if the therapy can reduce disease activity and improve kidney function. The…
Matched conditions: LUPUS
Phase: PHASE1 • Sponsor: LiveKidney.Bio • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
First human tests begin for potential new lupus treatment
Disease control Recruiting nowThis is an early safety study for a new drug called BMS-986326 for people with different types of lupus. The main goal is to see if the drug is safe and how the body processes it when given in increasing doses. Researchers will also check if the drug affects certain immune cells …
Matched conditions: LUPUS
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Stanford tests if a 2-Hour online class can match weeks of pain therapy
Symptom relief Recruiting nowThis study is comparing two online programs to see which works better for managing chronic pain. One is an 8-week cognitive behavioral therapy course, and the other is a single 2-hour skills class. Researchers at Stanford University are recruiting 1,650 adults with ongoing pain t…
Matched conditions: LUPUS
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Virtual therapy trial aims to ease debilitating pain for lupus sufferers
Symptom relief Recruiting nowThis study is testing whether an online group therapy program can help reduce chronic pain and improve quality of life for people with lupus who also have fibromyalgia. Researchers want to see if this emotional awareness therapy is safe and effective when delivered through video …
Matched conditions: LUPUS
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Mar 12, 2026 13:52 UTC
-
Massive 10-Year health data hunt launched for brain inflammation mysteries
Knowledge-focused Recruiting nowThis is a long-term research project gathering health information from 10,000 people in the U.S. to build a detailed picture of brain inflammation and related conditions like Long COVID, ME/CFS, and autoimmune diseases. Participants, including both affected and healthy individual…
Matched conditions: LUPUS
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC
-
Scientists launch major study to unlock the mystery of fatigue
Knowledge-focused Recruiting nowThis study aims to better understand the different types and causes of fatigue, which is a common symptom in many conditions like cancer, lupus, and chronic fatigue syndrome. Researchers will enroll about 700 adults, both with and without fatigue, to complete questionnaires, phys…
Matched conditions: LUPUS
Sponsor: National Center for Complementary and Integrative Health (NCCIH) • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC